Remote Working May Help Delay Retirement Of Senior US FDA Officials
Executive Summary
CBER director Peter Marks notes efforts to bring in more staff to deal with ‘crushing’ workload; says there has been no political pressure for the center to approve COVID-19 booster shots.
You may also be interested in...
US FDA CDER, CBER Staff Say Pandemic Had Negative Effect On Hiring, Retention
Human resource managers also worried that since universal teleworking was valued by employees, a return to pre-pandemic conditions could cause a mass exodus.
US FDA Vaccination Rate Exceeds 96%, But Will It Lead To More In-Office Work?
Teleworking remains popular among employees and could be a powerful perk to help FDA recruiting.
FDA Schedules Vaccines Panel On COVID Boosters As Questions Linger About Data Adequacy
VRBPAC could help restore some confidence in any booster decision after White House moved ahead of FDA and CDC, but without hard outcomes data and no proven immune correlate of protection, support for Pfizer’s sBLA at the 17 September advisory committee meeting seems far from guaranteed.